Deep Vein Thrombosis (DVT):グローバル臨床試験レビューH1, 2013...市場調査レポートについてご紹介

【英文タイトル】Deep Vein Thrombosis (DVT) Global Clinical Trials Review, H1, 2013

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 7
Introduction 8
Deep Vein Thrombosis (DVT) 8
Report Guidance 8
Clinical Trials by Region 9
Clinical Trials by Country 10
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12
Top Five Countries Contributing to Clinical Trials in Europe 13
Top Countries Contributing to Clinical Trials in North America 14
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 15
Top Five Countries Contributing to Clinical Trials in Central and South America 16
Clinical Trials by BRIC Nations 17
Clinical Trials by G7 Nations 18
Clinical Trials in G7 Nations by Trial Status 19
Clinical Trials by E7 Nations 20
Clinical Trials in E7 Nations by Trial Status 21
Clinical Trials by Phase 22
In Progress Trials by Phase 23
Clinical Trials by Trial Status 24
Unaccomplished Trials of Deep Vein Thrombosis (DVT) 25
Subjects Recruited Over a Period of Time 28
Prominent Sponsors 29
Top Companies Participating in Deep Vein Thrombosis (DVT) Therapeutics Clinical Trials 31
Prominent Drug Comparison 33
Clinical Trial Profiles 34
Clinical Trial Overview of Top Companies 34
Bayer AG 34
Clinical Trial Overview of Bayer AG 34
GlaxoSmithKline plc 36
Clinical Trial Overview of GlaxoSmithKline plc 36
Bristol-Myers Squibb Company 37
Clinical Trial Overview of Bristol-Myers Squibb Company 37
Sanofi 38
Clinical Trial Overview of Sanofi 38
Daiichi Sankyo, Inc. 39
Clinical Trial Overview of Daiichi Sankyo, Inc. 39
Pfizer Inc. 40
Clinical Trial Overview of Pfizer Inc. 40
AstraZeneca PLC 41
Clinical Trial Overview of AstraZeneca PLC 41
Daiichi Sankyo Company, Limited 42
Clinical Trial Overview of Daiichi Sankyo Company, Limited 42
Boehringer Ingelheim GmbH 43
Clinical Trial Overview of Boehringer Ingelheim GmbH 43
LEO Pharma A/S 44
Clinical Trial Overview of LEO Pharma A/S 44
Novartis AG 45
Clinical Trial Overview of Novartis AG 45
Daiichi Sankyo Europe GmbH 46
Clinical Trial Overview of Daiichi Sankyo Europe GmbH 46
Diakron Pharmaceuticals, Inc. 47
Clinical Trial Overview of Diakron Pharmaceuticals, Inc. 47
ThromboGenics NV 48
Clinical Trial Overview of ThromboGenics NV 48
Green Cross Corporation 49
Clinical Trial Overview of Green Cross Corporation 49
Bayside Health 50
Clinical Trial Overview of Bayside Health 50
Portola Pharmaceuticals, Inc. 51
Clinical Trial Overview of Portola Pharmaceuticals, Inc. 51
Diagnostica Stago SAS 52
Clinical Trial Overview of Diagnostica Stago SAS 52
AGEN Biomedical Limited 53
Clinical Trial Overview of AGEN Biomedical Limited 53
Generex Biotechnology Corporation 54
Clinical Trial Overview of Generex Biotechnology Corporation 54
Clinical Trial Overview of Top Institutes / Government 55
Brigham and Women’s Hospital 55
Clinical Trial Overview of Brigham and Women’s Hospital 55
Hamilton Health Sciences 56
Clinical Trial Overview of Hamilton Health Sciences 56
Ottawa Hospital Research Institute 57
Clinical Trial Overview of Ottawa Hospital Research Institute 57
McMaster University 58
Clinical Trial Overview of McMaster University 58
Academic Medical Centre 59
Clinical Trial Overview of Academic Medical Centre 59
Intermountain Healthcare, Inc. 60
Clinical Trial Overview of Intermountain Healthcare, Inc. 60
Jewish General Hospital 61
Clinical Trial Overview of Jewish General Hospital 61
St. Orsola Hospital 62
Clinical Trial Overview of St. Orsola Hospital 62
Azienda Ospedaliera Universitaria Policlinico catania 63
Clinical Trial Overview of Azienda Ospedaliera Universitaria Policlinico catania 63
Assistance Publique – Hopitaux de Paris 64
Clinical Trial Overview of Assistance Publique – Hopitaux de Paris 64
University Hospital, Grenoble 65
Clinical Trial Overview of University Hospital, Grenoble 65
Washington University School of Medicine 66
Clinical Trial Overview of Washington University School of Medicine 66
University of Pennsylvania 67
Clinical Trial Overview of University of Pennsylvania 67
University of Oklahoma 68
Clinical Trial Overview of University of Oklahoma 68
University Hospital Basel 69
Clinical Trial Overview of University Hospital Basel 69
Leiden University Medical Center 70
Clinical Trial Overview of Leiden University Medical Center 70
National Taiwan University Hospital 71
Clinical Trial Overview of National Taiwan University Hospital 71
Centre Hospitalier Universitaire de Saint Etienne 72
Clinical Trial Overview of Centre Hospitalier Universitaire de Saint Etienne 72
Rambam Health Care Campus 73
Clinical Trial Overview of Rambam Health Care Campus 73
The University of Chicago 74
Clinical Trial Overview of The University of Chicago 74
Five Key Clinical Profiles 75
Appendix 180
Abbreviations 180
Definitions 180
Research Methodology 181
Secondary Research 181
About GlobalData 182
Contact Us 182
Disclaimer 182
Source 183


【レポート販売概要】

■ タイトル:Deep Vein Thrombosis (DVT):グローバル臨床試験レビューH1, 2013
■ 英文:Deep Vein Thrombosis (DVT) Global Clinical Trials Review, H1, 2013
■ 発行日:2013年6月17日
■ 調査会社:GlobalData
■ 商品コード:GDATA403161129
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。